Nordic News, Business and Life in Asia
The Danish pharmaceutical giant Novo Nordisk has reported encouraging results from a new diabetes and weight loss drug developed with a Chinese partner, Fierce Biotech reports. The candidate, known as …
Novo Nordisk tests China-developed drug for obesity and diabetes while competition is growing Read More
Novo Nordisk will lose patent protection for its blockbuster drug Ozempic in several major markets from Saturday. The patent expiry opens the door for other manufacturers to produce cheaper generic …
Novo Nordisk will lose patent protection on Saturday Read More
Novo Nordisk, the Danish pharmaceutical giant renowned for its diabetes and weight-loss medications, including the blockbuster drugs Ozempic and Wegovy, announced impressive third-quarter earnings despite challenges with production constraints. Novo …
Novo Nordisk reports strong profits despite production constraints Read More
The Danish pharmaceutical company Novo Nordisk has signes a deal with a Indonesian state-owned drug company called Bio Farma. Their goal is to produce insulin to fight diabetes within Indonesia. …
Novo Nordisk will help combat diabetes in Indonesia Read More
The popular weight loss medicin Wegovy by the Danish phamaceutical firm Novo Nordisk has been approved for consumers in China. This has been confirmed by an employee at the company. …
Wegovy approved in China Read More A Chinese drugmaker applied for approval on 3 April 2024 to sell their biosimilar Ozempic drug in China. This potentially challenges the expansion plans of Novo Nordisk in China, who …
Chinese drugmaker seeks approval of Ozempic-like drug Read More
Novo Nordisk has established itself in the medicine market with patents that earn billions. Mainly due to the obesity drug Wegovy and the diabetes medicine Ozempic. Both consists of an …
Approaching patent expiration in China may threaten Novo’s billion-dollar business Read More
Danish pharmaceutical company Novo Nordisk has surpassed LVMH and is now Europe’s most valuable listed company. LVMH, the world’s biggest luxury retailer, is currently suffering due to growing concerns about …
Danish Novo Nordisk surpasses LVMH as Europe’s most valuable company Read More
Danish pharmaceutical titan Novo Nordisk has applied to China’s drug regulator to widen the range of use of its diabetes medicine Ozempic. In the US Ozempic is also used as …
Novo Nordisk’s diet drug may land in China soon Read More
Danish Novo Nordisk reported Thursday, May 4, a 39% increase in first-quarter profits, due to the company’s sales of obesity treatments. From January to March, net profit reached 19.8 billion …
Novo Nordisk experience big profit rise due to obesity treatments Read More